Expression of Erythroid Differentiation Regulator 1 (Erdr1) in Vitiligo

Not Applicable

• Conditions: Erythroid Differentiation Regulator 1 (Erdr1) Cytokine
• Interventions: Other: skin biopsy

• Registration Number: NCT03377998
• Lead Sponsor: Cairo University

Brief Summary

Expression of Erythroid differentiation regulator 1 (Erdr1) cytokine in vitiligo

Detailed Description

Not available

Study Timeline

• Status Verified: 2017-12
• Study First Submitted: 2017-12-11
• Study First Submitted QC: 2017-12-14
• Last Update Submitted: 2017-12-14
• Study First Posted: 2017-12-19
• Last Update Posted: 2017-12-19
• Study Start: 2018-01
• Primary Completion: 2018-07
• Study Completion: 2018-07

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Patients with generalized non-segmental vitiligo.
• Both sexes.
• Age >18 years old.
• New cases or cases not receiving any medication for at least 3 months ago.

Read More

Exclusion Criteria

• Segmental or Universal vitiligo
• Autoimmune diseases

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
vitiligo patients	skin biopsy	lesional skin biopsy to measure ERDR1 level
controls	skin biopsy	normal skin biopsy to measure ERDR1 level

Primary Outcome Measures

Name	Time	Method
Expression of tissue levels of erythroid differentiation regulator 1 (Erdr1) cytokine in patients of vitiligo	6 months	Expression of tissue levels of erythroid differentiation regulator 1 (Erdr1) cytokine in patients of vitiligo and comparing its level in normal subjects